National Breast Cancer Coalition

The Vision for Targeted Breast Cancer Therapies

Dennis Slamon, MD, PhD | Jonsson Comprehensive Cancer Center, UCLA

Date: May 5, 2013 | Run Time: 19:36 | Course Level: Advanced

Hear an analysis of where we are today and the vision for where we need to be in breast cancer. Understand the reality behind the numbers, what's changed in treatment and clinical trials, and whether prevention is finally becoming a focus. Listen to Dr. Dennis Slamon of UCLA, who was instrumental in the identification of the HER2/neu oncogene and the resulting treatment, trastuzumab (Herceptin®), which is hailed as the first triumph in an emerging wave of targeted therapies. His work continues to impact the breast and ovarian cancer fields with its innovative research.

You will learn:

  • Where we are today in treating breast cancer.
  • An update on targeted therapy research.
  • An update on HER2 research.

Please enter your email address to view this course:

   Please leave this field empty
NBCC is grateful to the WellPoint Foundation for their generous support of the Online Center for Advocacy Training.